Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
China
· Delayed Price · Currency is CNY 19.69
+0.06 (0.31%)
Mar 10, 2026, 11:30 AM CST
SHA:600529 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 689.63 | 942.99 | 775.8 | 618.29 | 591.09 | Upgrade
|
| Depreciation & Amortization | 395.08 | 384.77 | 325.13 | 295.17 | 240.64 | Upgrade
|
| Other Amortization | - | 0.38 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.45 | -0.33 | 5.73 | -4.53 | -0.59 | Upgrade
|
| Asset Writedown & Restructuring Costs | 153.51 | 62.82 | 48.82 | 48.25 | 61.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | -17.55 | -36.1 | -41.23 | -5.45 | -12.81 | Upgrade
|
| Provision & Write-off of Bad Debts | -3.95 | 2.13 | 11.42 | 12 | 10.87 | Upgrade
|
| Other Operating Activities | -5.3 | -16.45 | -9.62 | -22.23 | 6.25 | Upgrade
|
| Change in Accounts Receivable | 299.25 | -141.18 | -191.12 | -242.64 | -265.71 | Upgrade
|
| Change in Inventory | -520.12 | -280.14 | 125.87 | -355.41 | -155.06 | Upgrade
|
| Change in Accounts Payable | -390.26 | 288.01 | 6.88 | -100.67 | 275.3 | Upgrade
|
| Change in Other Net Operating Assets | -4.59 | -5.2 | -3.89 | 9.26 | 1.82 | Upgrade
|
| Operating Cash Flow | 576.92 | 1,165 | 1,048 | 252.44 | 750.44 | Upgrade
|
| Operating Cash Flow Growth | -50.48% | 11.17% | 315.14% | -66.36% | 32.58% | Upgrade
|
| Capital Expenditures | -231.86 | -647.79 | -671.53 | -710.71 | -809.26 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.2 | 0.63 | 2.21 | 11.18 | 3.45 | Upgrade
|
| Investment in Securities | 50 | -508 | -112 | -796 | -74 | Upgrade
|
| Other Investing Activities | 30.07 | 37.31 | 36.76 | 7.15 | 12.56 | Upgrade
|
| Investing Cash Flow | -148.59 | -1,118 | -744.57 | -1,488 | -867.25 | Upgrade
|
| Short-Term Debt Issued | - | - | 12.46 | 5.16 | - | Upgrade
|
| Total Debt Issued | - | - | 12.46 | 5.16 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 12.46 | 5.16 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,842 | - | Upgrade
|
| Common Dividends Paid | -370.34 | -464.53 | -199.08 | -178.49 | -178.49 | Upgrade
|
| Other Financing Activities | -6.41 | - | - | -0.96 | - | Upgrade
|
| Financing Cash Flow | -376.75 | -464.53 | -186.62 | 1,668 | -178.49 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5.79 | 15.61 | 9.69 | 20.19 | -6.64 | Upgrade
|
| Net Cash Flow | 57.38 | -401.72 | 126.48 | 452.42 | -301.94 | Upgrade
|
| Free Cash Flow | 345.06 | 517.27 | 376.45 | -458.27 | -58.82 | Upgrade
|
| Free Cash Flow Growth | -33.29% | 37.41% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 7.71% | 10.09% | 7.56% | -10.94% | -1.52% | Upgrade
|
| Free Cash Flow Per Share | 0.52 | 0.78 | 0.57 | -0.76 | -0.10 | Upgrade
|
| Cash Income Tax Paid | - | 274.56 | 252.97 | 137.17 | 166.19 | Upgrade
|
| Levered Free Cash Flow | 280.76 | 328.88 | 156.21 | -646.81 | -132.14 | Upgrade
|
| Unlevered Free Cash Flow | 281.08 | 328.89 | 156.36 | -646.64 | -131.96 | Upgrade
|
| Change in Working Capital | -633.04 | -175.16 | -68.07 | -689.05 | -146.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.